NEXT-GEN STEROIDS
Dead / Abandoned — Abandoned — failure to respond (as of 19 Oct 2023)
What this means for you
This application is over — abandoned 06 Oct 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88817601
- Mark type
- Stylized text
- Filed
- 02 Mar 2020
- Abandoned
- 06 Oct 2023
- Attorney of record
- Sean D. O'Brien
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of allergic states, collagen diseases, dermatologic diseases, edematous states, endocrine disorders, gastrointestinal diseases, hematological disorders, infectious diseases, neoplastic diseases, nervous system disorders, ophthalmic diseases, respiratory disorders, and rheumatic disorders
Owner
- Sparrow Pharmaceuticals, Inc., Portland, OR, US
Prosecution history
- 19 Oct 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 19 Oct 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 19 Oct 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 05 Jul 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Jul 2023 — NON-FINAL ACTION E-MAILED
- 05 Jul 2023 — NON-FINAL ACTION WRITTEN
- 02 Jul 2023 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 07 Jun 2023 — WITHDRAWN FROM PUB - OG REVIEW QUERY
- 07 Jun 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 May 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Nov 2022 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 23 May 2022 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 22 Nov 2021 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 24 May 2021 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 22 Nov 2020 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED